4/A: NCR Atleos Director Jeffry H. von Gillern Corrects Transaction Date in Amended SEC Filing

Jeffry H. von Gillern, a director of NCR Atleos Corp, filed an amended Form 4 to correct the date of an earlier transaction, with no changes to the originally disclosed information.

Summary

• Jeffry H. von Gillern, a director at NCR Atleos Corp, filed an amendment to a previously submitted Form 4.
• The amendment corrects the date of the earliest transaction from May 23, 2024, to May 21, 2024.
• The filing relates to the acquisition of 5,686 shares of common stock at a price of $28.14 on May 21, 2024.
• Following the reported transaction, von Gillern beneficially owns 12,503 shares of common stock directly.
• These shares were awarded as restricted stock units under the NCR Atleos Director Compensation Program and vest in 12 months, contingent upon continued service as a director.

Sentiment

Score: 7

Explanation: The document is a routine correction of a technical error in a regulatory filing. It doesn't indicate any significant positive or negative developments for the company, but the correction itself is a positive sign of diligence.

Future Outlook

The restricted stock units vest in 12 months after the grant date, subject to the reporting person's continued service as a director.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies. It provides transparency into the equity holdings of company insiders.

Comparison to Industry Standards

• Director compensation programs involving restricted stock units are standard practice among publicly listed companies like NCR Atleos.
• Vesting schedules of 12 months are also typical for such grants, aligning director interests with long-term company performance.
• Comparable companies such as Diebold Nixdorf and Glory also utilize equity-based compensation for their directors.

Stakeholder Impact

• The filing provides transparency to shareholders regarding director stock ownership.
• It assures stakeholders that the company is diligent in correcting errors in regulatory filings.

Key Dates